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Abstract 
 
The effect of acute consumption of a flavonol-rich cocoa drink on 
cerebral vasomotor reactivity in African Americans 
 
ByungMo Ku, M.S. Kin 
The University of Texas at Austin, 2014 
 
Supervisor:  Robert Matthew Brothers 
 
 
African Americans (AA) are at great risk of cardiovascular diseases (CVD) 
which can lead to brain damage, dementia, and endothelial dysfunction. Decreased nitric 
oxide (NO) bioavailability contributes cardiovascular disease in AA population. 
Flavonols of the subclass known as flavonoids that have several beneficial effects on 
cerebral blood flow and cerebral vasomotor reactivity(CVMR). This study investigated 
the effects of the acute consumption of a flavanol-rich cocoa drink on CVMR. Ten non-
smoking African American (6 males and 3 females) participants were randomly recruited. 
The subjects participated in two experimental sessions which were separated before and 
after the consumption of cocoa drink. For the pre-session, baseline CVMR was measured 
by the hypercapnia rebreathing (CVMR test) prior to the consumption of the cocoa drink 
and the again at 2h after consumption of one serving of the cocoa drink (45g of cocoa 
mixed with 8oz of cold water). Cerebral vascular conductance (CVC) was significantly 
 v 
increased in the post-study during hypercapnia rebreathing compared with the pre-
study(post-study: 3.649 ± 1.833 CVC % of baseline/mmHg, pre-study: 2.483 ± 1.418 
CVC % of baseline/mmHg vs. P < 0.05) Thus, CVMR was significantly increased in the 
post-study after the acute consumption of a flavonol-rich cocoa drink compared to the 
pre-study in AA.  
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CHAPTER 1  
INTRODUCTION 
 
1.1 Background 
Cardiovascular disease (CVD) is the leading cause of death in the United States 
(3). It is well known that African Americans are at greater risk for CVD (7). The 
relationship between cardiovascular disease in African Americans (AA) and major risk 
factors is complex; however, Anita et al. (7) suggested that hypertension, diabetes, and 
hypercholesterolemia are the primary risk factors for CVD which can lead to brain 
damage, dementia, and endothelial dysfunction in AA (10,15,16). Though the underlying 
mechanisms remain unclear, it has been recently suggested that decreased nitric oxide 
(NO) bioavailability contributes to cardiovascular disease in African American 
population (35,55,69). 
NO, which acts as a potent vasodilator, is a significant cellular signaling molecule 
included in vascular functioning, and NO induced from endothelial cells regulates 
cerebral blood flow (CBF) and vascular smooth muscle tone (36). Melikian et al., (55) 
have suggested that NO bioavailability is decreased in relatively young AA men, which 
likely leads to impaired endothelium-dependent vasodilation in AA (69). In addition, a 
previous study (48) has demonstrated that, structural rarefaction which is structural loss 
in microcirculation was induced by impaired endothelium-dependent vasodilation, 
resulting in an elevation in peripheral vascular resistance, and a subsequent elevation in 
arterial blood pressure. Endothelial dysfunction is a critical factor in the pathogenesis of 
cardiovascular diseases such as hypertension and stroke which can contribute to cognitive 
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impairment and Alzheimer’s disease by impairing vasodilation in the cerebral vasculature 
and damaging vascular endothelial cells in the brain (24,25,28,91).  
Cerebral vasomotor reactivity (CVMR) indicates the compensatory constrictive or 
dilatory ability of distal cerebral arteries to a vasoactive stimulus (29). In clinical 
practice, impaired CVMR, indicating a decreased cerebrovascular reserve, forecasts 
enhanced risk of ischaemic stroke (30, 31). It has been well described that a change of 
cerebral blood flow and of CVMR in systemic disease states such as hypertention, and 
diabetes (30-32). 
 African Americans, therefore, may have impaired cerebral vasomotor reactivity. 
This is also supported by our unpublished study which shows that African Americans 
have impaired cerebral vascular response to hypercapnia, stiffer arteries, and lower 
Vitamin D levels than Caucasian Americans.  
It is well known that flavonoid-rich foods can strongly affect the incidence and 
onset of cardiovascular and neurodegenerative diseases, and thus flavonoids-rich foods 
have been promising, particularly in the area of cardiovascular and cerebrovascular 
function. Cocoa powder includes a large percentage of flavonols of the subclass known as 
flavonoids that have several beneficial effects on the brain, vascular system and cerebral 
blood flow (22). Flavonoids in cocoa activate NO synthesis in healthy humans (21) by 
stimulating endothelial cells to provide NO via elevation of intracellular calcium level 
(26, 27). It has also been found that flavonoids interact with signalization cascades 
including protein and lipid kinases that contribute to the inhibition of neuronal death by 
apoptosis caused by neurotoxicants such as oxygen radicals, and support neuronal 
survival and synaptic plasticity. (22)  
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According to these findings, it is reasonable that the intake of flavonoids may 
have a positive effect with a particular emphasis on cerebrovascular system in African 
Americans. Our hypothesis is, therefore, that acute consumption of flavonol-rich cocoa 
drink may improve cerebrovascular vasomotor reactivity in African Americans.       
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1.2 Statement of purpose 
The purpose of the present investigation was to determine whether there are 
effects on cerebral vasomotor reactivity in healthy young African Americans. The 
specific objectives of the study were to; 
 
1. Determine whether the acute flavonoid consumption has a positive effect on 
cerebral vasomotor reactivity in African Americans 
 
1.3 Hypothesis 
In the current study, we tested the following hypotheses; 
 
1. The acute flavonoid consumption would improve the cerebral vasomotor 
reactivity in African Americans
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CHAPTER 2 
METHODOLOGY 
2.1 Subjects  
Ten non-smoking African American (6 males and 3 females) participants 
completed the study. Subject characteristics were (mean ± SD) 23.4 ± 0.8 years, 169.5 ± 
8.2 cm, 72.84 ± 12.1 kg, 25.3 ± 4.0 kg/m
2
 for age, height, weight, and BMI, respectively 
(Table 1). The African American subjects (ages 18-30; both genders) were recruited from 
the University of Texas at Austin and the large Austin area to participate in the study. All 
subjects completed a health questionnaire Subjects were excluded from the study 
following criteria: cardiovascular, neurological, metabolic, orthopedic, or cognitive 
diseases; currently taking medications to influence the autonomic nervous system and 
pregnant women and children (i.e. younger than 18). Subjects were asked to avoid 
vigorous exercise and alcoholic beverages for 24 hours and to avoid caffeine and food for 
12 hours before the protocol. Temperature and relative humidity were maintained at 
~24°C and 40% while conducting all experiments and procedures. The Institutional 
Review Board at The University of Texas at Austin approved all techniques and 
protocols used in the current study and written informed consent was obtained from all 
participants before testing.  
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2.2 Instrumentation and Measurements 
An electrocardiogram (ECG)(HP Patient Monitor, Agilent, Santa Clara, CA) 
interfaced with a cardiotachometer (CWE, Ardmore, PA) were continuously used to 
monitor heart rate and cardiac rhythms. A Penaz method (CNAP, Monitor 500, Austria) 
was used to record continuous finger arterial blood pressure. In addition, 
electrosphygmomanometry (Tango+; SunTech, Raleigh, NC) was used to measure 
intermittent blood pressure with auscultation of the brachial artery. Mean arterial blood 
pressure (MAP) was calculated as one-third pulse pressure plus diastolic blood pressure. 
A capnograph (VitalCap Capnograph Monitor, Oridion, Needham, MA) with a 
mouthpiece was continuously used to collect end-tidal carbon dioxide concentration 
(PETCO2) during all data collection periods and was used as an index of arterial carbon 
dioxide concentration.  
Transcranial Doppler ultrasonography was used to measure cerebral blood flow, 
which was indexed from the velocity (MCA Vmean) of blood flowing through the middle 
cerebral artery. The middle cerebral artery was figured through a 2-MHz Doppler probe 
(Multi-flow, DWL Elektronische Systeme, Singen, Germany) modified over the temporal 
window of the right or left middle cerebral artery until an optimal signal was clarified. A 
head strap was used to stabilize the Doppler probe for the duration of the study. An index 
of cerebral vascular conductance (CVCi) was calculated from the ratio of the middle 
cerebral artery blood velocity (MCA Vmean) to MAP acquired from the beat-to-beat 
arterial pressure measurement. Cerebral vasomotor reactivity (CVMR) was estimated 
based on changes in cerebral vascular conductance (CVCi; MCA Vmean/ MAP) in 
response to rebreathing-induced hypercapnia. The Delta raise in PETCO2 and the % 
change in CVCi were used to acquire its slope of regression line. To prevent hypoxic 
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events (i.e. cerebral hypoxia), oxygen (calculated by height and weight) was continuously 
provided during the CVMR test. 
 
2.3 Experimental Protocol 
The subjects were required to participate in two experimental sessions. These 
sessions were separated before and after the consumption of cocoa drink. For the pre-
session, baseline CVMR was measured prior to the consumption of the cocoa drink and 
the again at 2h after consumption (48g of cocoa mixed with 8oz of cold water). The 
cocoa powder (Hershey’s) used in this study consisted of sucralose, carrageenan, 
maltodextrin, salt, acesulfame potassium and sulfur dioxide. The nutrient content of the 
test drink is listed in table 1.  
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Nutritional Composition                 
Per serving 
Flavanol Test 
Drink 
Calories 149 
Fat, g (calculated) 2 
Sat fat, g 1 
Trans fat, g 0 
Cholesterol, mg 11 
Sodium, mg 364 
Carbohydrates, g 25 
Dietary fiber, g 5 
Sugar, g 17 
Protein, g 14 
Vitamin A, IU 10 
Vitamin C, mg 2 
Calcium, mg 429 
Iron, mg 1 
Magnesium, mg 113 
Potassium, mg 780 
Proanthocyanidins 1-10, mg 247.2 
  PACs 1 mers 64.8 
*Catechin, mg 17.8 
*Epicatechin, mg 47.0 
  PACs 2 mers 39.8 
  PACs 3 mers 25.4 
  PACs 4 mers 26.4 
  PACs 5 mers 22.1 
  PACs 6 mers 20.6 
  PACs 7 mers 18.7 
  PACs 8 mers 12.0 
  PACs 9 mers 9.6 
  PACs 10 mers 7.7 
Total Proanthocyanidins 
(DMAC), mg 
528.0 
Table 1. Nutritional Composition Per serving 
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Upon arriving at the laboratory, height and weight were measured, which were 
then used to calculate the rate of oxygen that was continuously provided during the 
CVMR test. Subjects were asked to take a rest quietly in a supine position on a patient 
bed. ECG electrodes were attached to trial participants to monitor heart rate, and 
electrosphygomanometer was used to obtain intermittent blood pressure. MAP was 
calculated as one-third of pulse pressure plus diastolic blood pressure. Finger cuffs were 
attached to two fingers to measure beat-by-beat arterial blood pressure throughout the 
trial (Penaz method). This instrumentation took approximately 15 minutes and was 
followed by a 6-minute period of baseline data collection with blood pressure measured 
via auscultation of the brachial artery in the final minute of this baseline period.  
A 2-MHz Doppler probe was then instrumented using a head strap for stabilizing 
and modified over the temporal window until the optimal signal was acquired. This 
modification was followed by the CVMR test. Subjects remained in a supine position and 
an adjusted mouthpiece was put into the mouth. Subjects went from breathing 
atmospheric air to rebreathing their own breathed-out air from a specialized rubber bag 
though mouthpiece, that has the ability to switch a valve. In addition, a tube connected to 
a capnograph was used to observe PETCO2 during the test. Before the CVMR test six-
minute baseline data were acquired and averaged to express baseline values for MCA 
Vmean, CVCi, and PETCO2. Participants went through a rebreathing procedure (CVMR 
test) after the baseline data collection. Subjects then began to rebreathe their own air by 
closing the valve to complete this procedure. This lead to an increase in PaCO2 (as 
indexed by PETCO2) and breath-by-breath data were collected until the delta increase in 
PETCO2 was achieved (see below), approximately 2-3 minutes. The rebreathing 
procedure ceased once subjects attained the target increase in PETCO2, which was delta 
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15 mmHg or if subjects felt dizziness, shortness of breath, and/or tingling or numbing 
sensations. 
 
2.4 Data Analysis 
MAP, MCA Vmean, subsequent calculation of CVCi and PETCO2 were estimated 
on a breath-by-breath basis and were sampled at 125 Hz via a data-acquisition system 
(Biopac System, Santa Barbara, CA).  
The last minute of the 6-minute baseline period was used for the baseline data 
analysis (MAP, PETCO2, and MCA Vmean, CVCi). The percent changes in CVC from the 
baseline value during hypercapnic rebreathing period were determined while absolute 
changes in PETCO2 from the baseline value were used. Pulse wave velocity was 
calculated as addressed above (see 3.1 Instrument and measurements). 
 
2.5 Statistical Analysis 
Descriptive analysis was carried out to represent the characteristics of the 
subjects. The means and standard deviation (SD) were used for continuous variables (e.g. 
age, height, weight, and BMI), and the numbers of subjects were appreaed for categorical 
variables (sex). The means and standard deviation were also appreared for continuous 
variables (HR, MAP, PETCO2, MCA Vmean, CVCi) at the 6-minute baseline before 
hypercapnic rebreathing period. Statistical significance between the first test and the 
second test was evaluated using paired t-test for hemodynamic variables at baseline (HR, 
MAP, PETCO2, MCA Vmean, CVCi). The linear regression was applied for calculating the 
slope of the percent changes in CVCi from baseline thru progressive hypercapnia with 
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respect to the delta changes in PETCO2 from the baseline. One-way repeated measures 
ANOVA was used to analyze differences in CVMR between the first test and the second 
test. The alpha level for statistical significance was used at 0.05. IBM SPSS statistics 
(Systat Software, Inc., Chicago, Illinois) was used for statistical analysis.
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CHAPTER 3  
RESULTS 
 
3.1 Subjects 
Nine African Americans participated in this study(six male and three female). Table 2 
displays participant characteristics. Average age of the participants was 23.4 ± 0.8 yrs. 
The participants’ average of height and weight were 169.5 ± 8.2 cm and 72.84 ± 12.1 kg. 
Average body mass index was 25.3 ± 4.0 kg/m2. 
 
 
 
 
 
 
Table 2. Subject Characteristics
Variables Subjects 
Age(yrs) 
Sex(m/f) 
BMI(kg/m2) 
Height(cm) 
Weight(kg) 
23.4 ± 0.8 
6/3 
25.3 ± 4.0 
169.5 ± 8.2 
72.84 ± 12.1 
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3.2 Cerebral Vasomotor Reactivity  
Hemodynamic information during eucapnic period (baseline) is shown in table 3. 
There were no significant differences in HR (pre-study : 67.6 ± 4.1 beats × min
-1
 vs. post-
study: 64.5 ± 6.0 beats × min
-1
, P = 0.07), MAP (pre-study: 97.5 ± 16.1mm Hg vs. post-
study: 95.1 ± 14.8 mmHg, P = 0.40), MCA Vmean (pre-study: 64.2 ± 19.0 cm × sec
-1
 vs. 
post-study: 60.0 ± 14.0 cm × sec
-1
, P = 0.22), and PETCO2 (pre-study: 43.5 ± 3.7 mm Hg 
vs. post-study: 44.0 ± 2.6 mm Hg, P = 0.72). cerebral vascular conductance (CVC) (pre-
study: 1.49 ± 0.5 cm × sec
-1
 × mmHg
-1
 vs. post-study: 1.37 ± 0.4 cm × sec
-1
 × mmHg
-1
, P = 
0.05). 
 
Table 3.  Hemodynamic state during eucapnia 
Variables 
Pre-study 
(n=9) 
Post-study 
 (n=9) 
P-value 
HR (beats×min
-1
) 67.6 ± 4.1 64.5 ± 6.0 0.07 
MAP (mmHg) 97.5 ± 16.1 95.1 ± 14.8 0.40 
MCA Vmean (cm×sec
-1
) 64.2 ± 19.0 60.0 ± 14.0 0.22 
PETCO2 (mmHg) 43.5 ± 3.7 44.0 ± 2.6 0.72 
CVC (cm × sec
-1
 × mmHg
-1
) 1.49 ± 0.5 1.37 ± 0.4 0.05 
 
Notes:  
BMI, body mass index, MAP, mean arterial pressure. CVC, cerebral vascular conductance.  MCA Vmean, 
middle cerebral artery mean velocity.  PETCO2, partial pressure of end-tidal carbon dioxide.  
Values are means ± SD. 
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 The slopes of the percent increase in CVC per mmHg increase in PaCO2 indexed 
by PETCO2 were significantly increased in the post-study relative to the pre-study (post-
study: 3.649 ± 1.833 CVC % of rebreathing/mmHg, pre-study: 2.483 ± 1.418 CVC % of 
rebreathing/mmHg vs. P < 0.05) (Figure 1). 
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CHAPTER 4 
DISCUSSION 
 
In this study, a hypercapnia intervention was used to induce an increased need for 
blood flow in the brain, caused by the vasodilatory effects of NO. This hypercapnia 
intervention measures possible changes of blood flow related to the effect of flavanol-rich 
cocoa drink on the endothelial NO system. This study found that the CVMR increased in 
AA after the acute consumption of flavanol-rich cocoa drink. CVC, which is an index of 
cerebral blood flow (CBF), was significantly higher in the post-study than in the pre-
study.  
Some previous animal and epidemiologic studies have demonstrated that 
flavonoids may act to reduce the risk of dementia, which is related to declined CBF 
(38,40). Fruit and vegetable polyphynolds play a role in decreasing the sensibility of the 
rat brain to damage from oxidative stress cauased by aging (39). Consuming flavonoids 
resulted in decreased risk of incident dementia in a cohort of over 1300 French elderly 
(18). One contributing factor is that the benefits of flavonoids include increased vascular 
function and improved CBF. Hollenberg et al (33) found that flavanol-rich cocoa-induced 
NO production displays a marked effect on blood vessels that play an essential role in 
brain activity in healthy individuals. In addition, Fisher et al (34) provided first evidence 
using the transcranial Doppler ultrasound (TCD) that flavanol-rich cocoa could induce 
increased mean flow velocity in the middle cerebral artery in healthy subjects. This likely 
contributes to the improvement of CVMR induced by the consumption of flavanol-rich 
cocoa drink.  
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Epidemiogical studies have found that African Americans are at higher risk of 
cardiovascular disease than Caucasian Americans (35). The prevalence of high blood 
pressure and type 2 diabetes in AA in the United States is particularly high (41, 42). 
Some intervention studies suggested that hypertension is related with lowering CBF, and 
that lowering BP causes an incline in CBF (45, 46). In humans, long-standing 
hypertension contributes to reductions in CBF, metabolism and cognitive function. (9) 
Type 2 diabetes-induced hyperglycemia and hyperinsulinemia surfeit free fatty acids, 
prothrombotic state contribute to endothelial dysfunction which may decrease CBF (14) 
(15). In addition, AA have a tendency to have the lower NO bioavilability which may be 
induced by high plasma asymmetrical dimethyl arginine. NO induced from endothelial 
cells controls cerebral blood flow (CBF) and vascular smooth muscle tone (36). Increased 
consumption of flavonoid-rich foods may decrease the risk of hypertension and 
stroke(43, 44). Some studies suggested that flavanol compounds have the ability to 
activate endothelial NO synthesis and contribute to activation of NO (37). Therefore, it is 
possible that the consumption of a flavonol-rich cocoa drink may increase cerebral blood 
flow through NO-induced vasodilation in the brain in the AA population as our study 
showed.   
The current study is the first to investigate the influence of flavanol-rich cocoa on 
CVMR in AA. The primary finding in this study is the improvement of CVMR in African 
Americans after the acute consumption of flavanol-rich cocoa drink. This finding is of 
special interest in the area of between CVMR and flavanols. To our knowledge, the 
interactions between flavonol-induced improvement in CVMR and ethnicity remains 
unclear, but the effect of the acute consumption of flavonol-rich cocoa drink on CVMR 
in African Americans could be a key step toward explaining the action of flavonoids in 
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the cerebrovasculature in AA.although the underlying mechanisms in the present study 
are not known.  
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